Melinda French Gates, through Pivotal Ventures, is committing $100 million in partnership with Wellcome Leap to accelerate research on women’s health conditions that have long been underfunded, including cardiovascular disease, autoimmune disorders, and mental health. The initiative will select two major projects by the end of 2026, aiming to deliver measurable breakthroughs within 3–5 years.
713-782-3777
